Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate the influence of warm IV fluids during delivery and cesarean section on perinatal outcomes.
Prospective randomized controlled trial. Assessing the influence of warmed parenteral fluids during delivery/cesarean section on the obstetrical and neonatal outcome. The investigators will randomize parturients during the active phase of labor to receive either body temperature warmed parenteral fluids or room temperature parenteral fluids. Both groups will receive the same fluid composition of 5% dextrose with normal saline. The investigators will compare the obstetrical and neonatal outcomes of the two groups.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Room temperature parenteral fluids | No Intervention | This group will receive IV room temperature fluids, which is the standard of care. The composition of the fluids given will be normal saline with 5% dextrose. | |
| Body temperature parenteral fluids | Experimental | This group will receive IV warmed fluids, body temperature, which is the experimental intervention. The composition of the fluids given will be normal saline with 5% dextrose. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Body temperature parenteral fluids | Other | 2 study groups shall receive the same parenteral fluids but at different temperatures. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Length of the second stage of labor | How much time did it take from complete cervical dilation to the delivery of the baby. | up to 5 hours from complete cervical dilation |
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of perineal tears and episiotomies | The prevalence of perineal tears and episiotomies that occurred during vaginal delivery | immediately after vaginal birth |
| Neonatal APGAR score | Comparison of the 1 minute and 5 minute APGAR score that the neonates received, between the groups. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Only females are pregnant. The baby can be of either sex
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Hanoch Schreiber, MD | Contact | 972-53-332-3248 | hanoch.schreiber@clalit.org.il | |
| Tal Weissbach, MD | Contact | 972-546-250-299 | ferbyt@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Hanoch Schreiber, MD | Clalit Health Services | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Meir Medical Center | Recruiting | Kfar Saba | Israel |
All primary and secondary outcome measures will be made available within 6 months of syudy completion
Not provided
Not provided
Not provided
Not provided
Not provided
Randomization two 2 groups according to temperature of IV fluids. One group will receive room temperature fluids and the other group will receive body temperature fluids.
Not provided
Not provided
Not provided
Not provided
| up to 5 minutes from delivery |
| The rate of prolonged second stage | The percentage of patients, in each group, that were defined with a prolonged second stage. The definition is more than 2 hours from complete cervical dilation until delivery of the baby in multipara patients and more than 3 hours from complete cervical dilation until delivery of the baby in nullipara patients. | immediately after completion of the delivery. |
| Meir Medical Center | Recruiting | Kfar Saba | Israel |
|